Biotechnologists harness biological systems, organisms, and cellular components to develop products and technologies that improve health, agriculture, and industry. Their work spans genetic engineering, microbiology, cell culture, and bioinformatics, with applications ranging from creating more efficient crops to producing life-saving pharmaceuticals. By manipulating DNA and proteins, biotechnologists contribute to advancements in medicine, such as personalized therapies, regenerative treatments, and targeted drug delivery systems. Their efforts also play a major role in industrial biotechnology, helping to create environmentally friendly alternatives like biodegradable plastics and biofuels.
Collaboration is key to the success of biotechnologists, as they work closely with molecular biologists, chemical engineers, and data scientists to bring innovations from the lab to the real world. In the healthcare sector, they develop and refine diagnostic tools, therapeutic proteins, and vaccine technologies that are essential to modern medicine. Their involvement in research and development accelerates the pipeline from scientific discovery to commercial application, ensuring that innovations reach those who need them most. Moreover, biotechnologists contribute to food security and environmental sustainability by engineering drought-resistant crops and bio-remediation techniques. Their versatile skill set and interdisciplinary approach position them as key players in addressing global challenges. With science evolving rapidly, biotechnologists continue to shape a more sustainable, healthy, and innovative future.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States